Suppr超能文献

单核细胞和早幼粒细胞髓系来源的抑制细胞可能有助于 G-CSF 诱导的单倍体相合异基因造血干细胞移植中的免疫耐受。

Monocytic and promyelocytic myeloid-derived suppressor cells may contribute to G-CSF-induced immune tolerance in haplo-identical allogeneic hematopoietic stem cell transplantation.

机构信息

Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.

出版信息

Am J Hematol. 2015 Jan;90(1):E9-E16. doi: 10.1002/ajh.23865.

Abstract

We investigated the effects of granulocyte colony-stimulating factor (G-CSF) on monocytic (M), promyelocytic (P), and granulocytic (G) myeloid-derived suppressor cells (MDSCs) both in bone marrow and peripheral blood of 20 healthy donors and the association of MDSCs subgroups with acute and chronic graft-versus-host disease (aGvHD/cGvHD) in 62 patients who underwent haplo-identical allogeneic hematopoietic stem cell transplantation (allo-HSCT). Patients who received a higher absolute counts of M-MDSCs or P-MDSCs exhibited lower incidence of grade II-IV aGvHD (P = 0.001; P = 0.031) and extensive cGvHD (P = 0.011; P = 0.021). In the multivariate analysis, absolute counts of MDSCs in allografts emerged as independent factors that reduced the occurrence of grade II-IV aGvHD (M-MDSCs: HR = 0.087, 95% CI = 0.020-0.381, P = 0.001; P-MDSCs: HR = 0.357, 95% CI = 0.139-0.922, P = 0.033) and extensive cGvHD (M-MDSCs: HR = 0.196, 95% CI = 0.043-0.894, P = 0.035; P-MDSCs: HR = 0.257, 95% CI = 0.070-0.942, P = 0.04). Delayed M-MDSC reconstitution was associated with aGvHD onset. The 3-year cumulative incidence of transplant related mortality and relapse, 3-year probability of disease-free survival, and overall survival did not differ significantly between these subgroups. Our results suggested that G-CSF-induced immune tolerance may be mediated by M/P-MDSCs in allo-HSCT.

摘要

我们研究了粒细胞集落刺激因子(G-CSF)对 20 名健康供者骨髓和外周血中单核细胞(M)、早幼粒细胞(P)和粒细胞(G)髓系来源抑制细胞(MDSCs)的影响,以及这些 MDSCs 亚群与 62 名接受半相合异基因造血干细胞移植(allo-HSCT)的患者中急性和慢性移植物抗宿主病(aGvHD/cGvHD)的关系。接受更高绝对值的 M-MDSC 或 P-MDSC 的患者发生 II-IV 级 aGvHD 的几率较低(P=0.001;P=0.031)和广泛的 cGvHD(P=0.011;P=0.021)。在多变量分析中,移植物中 MDSC 的绝对值被认为是降低 II-IV 级 aGvHD 发生的独立因素(M-MDSC:HR=0.087,95%CI=0.020-0.381,P=0.001;P-MDSC:HR=0.357,95%CI=0.139-0.922,P=0.033)和广泛的 cGvHD(M-MDSC:HR=0.196,95%CI=0.043-0.894,P=0.035;P-MDSC:HR=0.257,95%CI=0.070-0.942,P=0.04)。M-MDSC 重建延迟与 aGvHD 发病有关。这些亚组之间的移植相关死亡率和复发的 3 年累积发生率、无病生存的 3 年概率和总生存没有显著差异。我们的结果表明,allo-HSCT 中的 G-CSF 诱导的免疫耐受可能是由 M/P-MDSC 介导的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验